<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref19">
 <mixed-citation publication-type="journal" id="cit19">
  <name>
   <surname>Xia</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Liu</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Wang</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Xu</surname>
   <given-names>W.</given-names>
  </name>; 
  <name>
   <surname>Lan</surname>
   <given-names>Q.</given-names>
  </name>; 
  <name>
   <surname>Feng</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Qi</surname>
   <given-names>F.</given-names>
  </name>; 
  <name>
   <surname>Bao</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Du</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Liu</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Qin</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Sun</surname>
   <given-names>F.</given-names>
  </name>; 
  <name>
   <surname>Shi</surname>
   <given-names>Z.</given-names>
  </name>; 
  <name>
   <surname>Zhu</surname>
   <given-names>Y.</given-names>
  </name>; 
  <name>
   <surname>Jiang</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Lu</surname>
   <given-names>L.</given-names>
  </name>
  <article-title>Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion</article-title>. 
  <source>Cell Res.</source>
  <year>2020</year>, 
  <volume>30</volume> (
  <issue>4</issue>), 
  <fpage>343</fpage>â€“
  <lpage>355</lpage>. 
  <pub-id pub-id-type="doi">10.1038/s41422-020-0305-x</pub-id>.
  <pub-id pub-id-type="pmid">32231345</pub-id>
 </mixed-citation>
</ref>
